Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
W van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P Bossi, R Miceli, L D Locati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
M Schlumberger, R Elisei, S Müller, et al.
Tumori
|
January 24, 2026
Medical decision analysis for personalized oncology at the patient bedside
P G Casali, L Licitra, S Provenzano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L D Locati, F Perrone, B Cortelazzi, et al.
Oral Oncology
|
April 8, 2026
A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
M Cossu Rocca, A Esposito, S Vecchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
S Cavalieri, F Perrone, R Miceli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2017
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
N Basset-Séguin, A Hauschild, R Kunstfeld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
A Psyrri, C Fortpied, G Koutsodontis, et al.
ESMO Open
|
October 30, 2025
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
E Colombo, S Cavalieri, A Vingiani, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
W van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P Bossi, R Miceli, L D Locati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
M Schlumberger, R Elisei, S Müller, et al.
Tumori
|
January 24, 2026
Medical decision analysis for personalized oncology at the patient bedside
P G Casali, L Licitra, S Provenzano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L D Locati, F Perrone, B Cortelazzi, et al.
Oral Oncology
|
April 8, 2026
A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
M Cossu Rocca, A Esposito, S Vecchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
S Cavalieri, F Perrone, R Miceli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2017
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
N Basset-Séguin, A Hauschild, R Kunstfeld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
A Psyrri, C Fortpied, G Koutsodontis, et al.
ESMO Open
|
October 30, 2025
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
E Colombo, S Cavalieri, A Vingiani, et al.
Page
of 11